Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$179.4K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Keenova Therapeutics plc |
| MEXER◆ |
| 2,685 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 2 | — | Keenova Therapeutics plc | DTOISS◆ | 2,197 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | — | Keenova Therapeutics plc | FTAX | 619 | — | — | -9.0% | Open the original filing on SEC.gov |
| Jun 2 | — | Keenova Therapeutics plc | MEXER | 2,685 | — | — | +64.3% | Open the original filing on SEC.gov |
| May 14 | MYGN | Myriad Genetics INC | PBUY | 7,500 | $3.69 | $27.6K | +8.3% | Open the original filing on SEC.gov |
| May 13 | ZTS | Zoetis Inc. | PBUY | 2,000 | $75.88 | $151.8K | +7.7% | Open the original filing on SEC.gov |